Euclises is a startup based in the United States.
Euclises develops targeted cancer therapies that prevent tumor immune evasion and kill cancer by disrupting the tumor microenvironment, focusing on selecting patients and optimizing treatment efficacy.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.